Engelsk titel: The genome and the consumer
Läs online
Författare:
Christiansen, Gunna
Email: gunna@biomed.au.dk
Språk: Dan
Antal referenser: 17
Dokumenttyp:
Översikt
UI-nummer: 15017711
Sammanfattning
Consumergenetics has developed so fast that it became possible for consumers to obtain genome risk information based on single nucleotide polymorphisms data of over 250 diseases/conditions for just 99 USD. In November 2013, the
American Food and Drug Administration (FDA) ordered the company 23andMe to stop returning health results because they found a lack of scientific evidence of the reposted disease risks. The ethical dilemmas associated with this are
reviewed, and the recommendations are described in genome testing. Ethical dilemmas in relation direct-to-consumer testing are discussed.